Research across borders

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find studies Explore world registries Peptide directory

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 17:56 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Not applicableNot yet recruitingINTERVENTIONAL

Terlipressin vs. Somatostatin in Cirrhotic Patients With Acute Variceal Bleeding and Renal Dysfunction

ClinicalTrials.gov · NCT07252401 · Registry updated: 2026-08-27

Condition / research focus: Liver Cirrhosis
Sponsor: General Hospital of Shenyang Military Region
Countries with listed sites: China
Registry dates and results: Start: 2026-09-25. Completion: 2028-03-31 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

2-4 mg of terlipressin (drug) — also listed as: Terlivaz
3 mg of somatostatin (drug) — also listed as: Stilamin

Where the study takes place — 1 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

Department of Gastroenterology, General Hospital of Northern Theater Command (formerly called General Hospital of Shenyang Military Area)
Shenyang, Liaoning, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableEnrolling by invitationOBSERVATIONAL

International Multi-center Retrospective Study of Patients With Serum Sodium ≤110 mmol/L to Determine the Relationship Between Osmotic Demyelination Syndrome (ODS) and Rapid Correction of Hyponatremia

ClinicalTrials.gov · NCT07576036 · Registry updated: 2026-08-26

Condition / research focus: Hyponatremia Symptomatic; Osmotic Demyelination Syndrome; Cerebral Edema
Sponsor: Rochester General Hospital
Countries with listed sites: United States
Registry dates and results: Start: 2023-11-01. Completion: 2026-09-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Hypertonic 3% saline (drug) — also listed as: Desmopressin, 5% dextrose in water

Where the study takes place — 1 listed sites

University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

Bedtime Device Restriction and Desmopressin in PMNE.

ClinicalTrials.gov · NCT07776977 · Registry updated: 2026-08-24

Condition / research focus: Primary Monosymptomatic Nocturnal Enuresis
Sponsor: Al-Azhar University
Countries with listed sites: Egypt
Registry dates and results: Start: 2026-08-20. Completion: 2027-07 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desmopressin (drug)
Bedtime digital-device restriction (behavioral)

Where the study takes place — 1 listed sites

Department of Urology, Al-Hussein and Sayed Galal University Hospitals, Al-Azhar University
Cairo, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Copeptin and Acute Coronary Syndrome Without ST-segment Elevation

ClinicalTrials.gov · NCT01334645 · Registry updated: 2026-08-06

Condition / research focus: Chest Pain
Sponsor: University Hospital, Clermont-Ferrand
Countries with listed sites: France
Registry dates and results: Start: 2011-03. Completion: 2012-03 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Copeptin (other)

Where the study takes place — 1 listed sites

CHU Clermont-Ferrand
Clermont-Ferrand, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableNot yet recruitingINTERVENTIONAL

Terlipressin vs Placebo to Reduce Bleeding in Fibroid Surgery

ClinicalTrials.gov · NCT07746349 · Registry updated: 2026-08-05

Condition / research focus: Uterine Fibroids (Leiomyoma); Uterine Myoma; Leiomyoma
Sponsor: Sevil Cankaya
Countries with listed sites: No country reported
Registry dates and results: Start: 2026-08-01. Completion: 2027-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

terlipressin (vasoconstrictor) (drug)
Placebo (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Vasopressin for Septic Shock Pragmatic Trial

ClinicalTrials.gov · NCT06217562 · Registry updated: 2026-08-03

Condition / research focus: Septic Shock
Sponsor: Intermountain Health Care, Inc.
Countries with listed sites: United States
Registry dates and results: Start: 2024-02-01. Completion: 2026-06-06 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vasopressin (drug)
Recommendation to use a lower initiation threshold for vasopressin (other)
Recommendation to use a higher initiation threshold for vasopressin (other)

Where the study takes place — 13 listed sites

Cassia Regional Hospital
Burley, Idaho, United States
Site recruitment: Not reported
American Fork Hospital
American Fork, Utah, United States
Site recruitment: Not reported
Cedar City Hospital
Cedar City, Utah, United States
Site recruitment: Not reported
Layton Hospital
Layton, Utah, United States
Site recruitment: Not reported
Logan Regional Hospital
Logan, Utah, United States
Site recruitment: Not reported
Intermountain Medical Center
Murray, Utah, United States
Site recruitment: Not reported
McKay-Dee Hospital
Ogden, Utah, United States
Site recruitment: Not reported
Park City Hospital
Park City, Utah, United States
Site recruitment: Not reported
Utah Valley Hospital
Provo, Utah, United States
Site recruitment: Not reported
Riverton Hospital
Riverton, Utah, United States
Site recruitment: Not reported
LDS Hospital
Salt Lake City, Utah, United States
Site recruitment: Not reported
Alta View Hospital
Sandy City, Utah, United States
Site recruitment: Not reported
St. George Regional Hospital
St. George, Utah, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Intraoperative Continuous Terlipressin Infusion is Associated With Reduced Severe Postoperative Complications After Laparoscopic Hepatectomy: a Prospective Propensity Score-matched Cohort Study

ClinicalTrials.gov · NCT07719933 · Registry updated: 2026-07-28

Condition / research focus: Liver Neoplasms; Postoperative Complications
Sponsor: First Affiliated Hospital, Sun Yat-Sen University
Countries with listed sites: China
Registry dates and results: Start: 2024-04-01. Completion: 2025-05-14 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

terlipressin (drug)

Where the study takes place — 1 listed sites

The First Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1RecruitingINTERVENTIONAL

Mifepristone vs Misoprostol

ClinicalTrials.gov · NCT06502158 · Registry updated: 2026-07-24

Condition / research focus: Cervical Preparation
Sponsor: Montefiore Medical Center
Countries with listed sites: United States
Registry dates and results: Start: 2024-10-31. Completion: 2027-06 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Mifepristone (drug)
Misoprostol (drug) — also listed as: Cytotec

Where the study takes place — 1 listed sites

Montefiore Medical Center
The Bronx, New York, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4Enrolling by invitationINTERVENTIONAL

Randomized Controlled Clinical Study on the Prophylactic Intraoperative Use of Desmopressin in Complex Sellar Region Tumors

ClinicalTrials.gov · NCT07712328 · Registry updated: 2026-07-17

Condition / research focus: Craniopharyngiomas; Pituitary Macroadenoma; Sellar and Suprasellar Masses
Sponsor: Zhaoyun Zhang
Countries with listed sites: China
Registry dates and results: Start: 2026-06-02. Completion: 2028-09-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desmopressin (DDAVP) (drug)
Control (other)

Where the study takes place — 1 listed sites

Huashan Hospital
Shanghai, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

"SALT Trial" Study of Ascending Levels of Tolvaptan in Hyponatremia

ClinicalTrials.gov · NCT00072683 · Registry updated: 2026-07-13

Condition / research focus: Hyponatremias; Water Intoxication; Inappropriate ADH Syndrome; Water-Electrolyte Imbalances
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Countries with listed sites: United States
Registry dates and results: Start: 2003-04-01. Completion: 2005-12-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

tolvaptan (drug)
placebo matching tolvaptan (drug)

Where the study takes place — 23 listed sites

VA Greater Los Angeles Health Care Ctr
Los Angeles, California, United States
Site recruitment: Not reported
UCLA
Los Angeles, California, United States
Site recruitment: Not reported
UCSF Medical Center
San Francisco, California, United States
Site recruitment: Not reported
Aurora Denver Cardiology Association
Denver, Colorado, United States
Site recruitment: Not reported
University of Colorado Health Science Center
Denver, Colorado, United States
Site recruitment: Not reported
University of Florida Gainesville
Gainesville, Florida, United States
Site recruitment: Not reported
Charlotte Heart Group Research Ctr
Port Charlotte, Florida, United States
Site recruitment: Not reported
Medical College of Georgia
Augusta, Georgia, United States
Site recruitment: Not reported
Northwestern University
Chicago, Illinois, United States
Site recruitment: Not reported
University of Chicago
Chicago, Illinois, United States
Site recruitment: Not reported
University of Iowa Hospital
Iowa City, Iowa, United States
Site recruitment: Not reported
Minneapolis VA Medical Center
Minneapolis, Minnesota, United States
Site recruitment: Not reported
Washington University Ctr for Clinical Studies
St Louis, Missouri, United States
Site recruitment: Not reported
Mercury Street Medical
Butte, Montana, United States
Site recruitment: Not reported
Northshore University Hospital
Great Neck, New York, United States
Site recruitment: Not reported
Facility not reported
New York, New York, United States
Site recruitment: Not reported
University of North Carolina, Div. of Cardiology
Chapel Hill, North Carolina, United States
Site recruitment: Not reported
University Hospitals of Cleveland
Cleveland, Ohio, United States
Site recruitment: Not reported
Ohio State University Medical Center
Columbus, Ohio, United States
Site recruitment: Not reported
The Arthur P. Noyes Research Foundation
Norristown, Pennsylvania, United States
Site recruitment: Not reported
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
Site recruitment: Not reported
Baptist Clinical Research Ctr
Memphis, Tennessee, United States
Site recruitment: Not reported
Tennessee Center for Clinical Trials
Tullahoma, Tennessee, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableActive, not recruitingINTERVENTIONAL

Effect of Terlipressin for Intraoperative Blood Pressure Management in Kidney Transplantation

ClinicalTrials.gov · NCT06855758 · Registry updated: 2026-07-13

Condition / research focus: Kidney Transplant; Delayed Graft Function; Intraoperative Hypotension
Sponsor: Beijing Friendship Hospital
Countries with listed sites: China
Registry dates and results: Start: 2025-03-06. Completion: 2027-06 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

terlipressin (drug)
Placebo (Normal Saline) (drug)

Where the study takes place — 1 listed sites

Beijing Friendship Hospital
Beijing, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableNot yet recruitingOBSERVATIONAL

Effect of Adding Vasopressin on Cardiac Output, Blood Pressure, Diuresis, and Tissue Perfusion Indices in Patients With Septic Shock

ClinicalTrials.gov · NCT07697144 · Registry updated: 2026-07-13

Condition / research focus: Septic Shock and Use of Vasopressin
Sponsor: Assistance Publique - Hôpitaux de Paris
Countries with listed sites: France
Registry dates and results: Start: 2026-08-01. Completion: 2029-09-01 (may be estimated). No results posted in this registry response.

Products and interventions (0)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Where the study takes place — 8 listed sites

CHU d'Angers
Angers, France
Site recruitment: Not reported
CH de Dieppe
Dieppe, France
Site recruitment: Not reported
Hôpital Bicêtre
Le Kremlin-Bicêtre, France
Site recruitment: Not reported
GHE, Hôpital Louis Pradel, HCL
Lyon, France
Site recruitment: Not reported
GHS - Hôpital Lyon Sud, HCL
Lyon, France
Site recruitment: Not reported
Hôpital Nord, AP-HM
Marseille, France
Site recruitment: Not reported
CHU Rennes - Site Pontchaillou
Rennes, France
Site recruitment: Not reported
Hôpital Hautepierre, Hôpitaux Universitaires de Strasbourg
Strasbourg, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Study of Ascending Levels of Tolvaptan in Hyponatremia

ClinicalTrials.gov · NCT00201994 · Registry updated: 2026-07-13

Condition / research focus: Hyponatremia
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Countries with listed sites: Germany
Registry dates and results: Start: 2003-11-01. Completion: 2005-07-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tolvaptan (drug) — also listed as: Samsca, OPC-41061
Placebo (drug)

Where the study takes place — 1 listed sites

Universitatskilinikum Carl
Gustav Carus, Dresden, Germany
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Serum Biomarkers to Predict Response to Angiotensin II in Septic Shock

ClinicalTrials.gov · NCT05824767 · Registry updated: 2026-07-02

Condition / research focus: Septic Shock; Vasodilatory Shock
Sponsor: University of New Mexico
Countries with listed sites: United States
Registry dates and results: Start: 2023-04-17. Completion: 2025-03-12 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Angiotensin II (drug) — also listed as: Giapreza

Where the study takes place — 1 listed sites

University of New Mexico Health Sciences Center
Albuquerque, New Mexico, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4Not yet recruitingINTERVENTIONAL

Angiotensin II for Post Cardiac Surgery Vasoplegia (ANGII_V)

ClinicalTrials.gov · NCT07671365 · Registry updated: 2026-06-26

Condition / research focus: Vasoplegic Shock; Cardiopulmonary Bypass; Vasoplegia
Sponsor: Methodist Healthcare System of San Antonio
Countries with listed sites: No country reported
Registry dates and results: Start: 2026-07. Completion: 2030-08 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Angiotensin II (Giapreza®) (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase not reported / not applicableActive, not recruitingOBSERVATIONAL

Samsca Post-marketing General Drug Use-results Survey in Patients With Hyponatremia in SIADH

ClinicalTrials.gov · NCT04790175 · Registry updated: 2026-06-22

Condition / research focus: Antidiuretic Hormone, Inappropriate Secretion
Sponsor: Otsuka Pharmaceutical Co., Ltd.
Countries with listed sites: Japan
Registry dates and results: Start: 2021-03-29. Completion: 2030-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tolvaptan (SAMSCA) (drug)

Where the study takes place — 1 listed sites

Pharmacovigilance Department
Osaka, Osaka, Japan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4Active, not recruitingINTERVENTIONAL

Angiotensin 2 for AKI After OLT

ClinicalTrials.gov · NCT04592744 · Registry updated: 2026-06-12

Condition / research focus: Cirrhosis, Liver; End Stage Liver DIsease; Acute Kidney Injury; Liver Transplant; Complications
Sponsor: University of California, Los Angeles
Countries with listed sites: United States
Registry dates and results: Start: 2022-04-08. Completion: 2026-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Angiotensin II (drug)
Norepinephrine (drug) — also listed as: Vasopressin, Epinephrine

Where the study takes place — 1 listed sites

Ronald Reagan UCLA Medical Center, Department of Anesthesiology & Perioperative Medicine
Los Angeles, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Vasopressin and Epinephrine Versus Epinephrine Alone in Cardiac Arrest

ClinicalTrials.gov · NCT00127907 · Registry updated: 2026-06-11

Condition / research focus: Cardiac Arrest
Sponsor: Hospices Civils de Lyon
Countries with listed sites: France
Registry dates and results: Start: 2004-05-02. Completion: 2007-10-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

epinephrine (1 mg/1 mL) (drug)
arginine-vasopressin (40 UI/2 mL) (drug)

Where the study takes place — 1 listed sites

Centre Hospitalier Lyon Sud
Pierre-Bénite, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2 / Phase 3CompletedINTERVENTIONAL

Intranasal Vasopressin Treatment in Children With Autism

ClinicalTrials.gov · NCT03204786 · Registry updated: 2026-06-04

Condition / research focus: Autism; Autism Spectrum Disorder; ASD
Sponsor: Stanford University
Countries with listed sites: United States
Registry dates and results: Start: 2018-02-20. Completion: 2024-03-18 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vasopressin (USP) Injectable Solution [Vasostrict] (drug)
Placebo (drug)

Where the study takes place — 1 listed sites

Stanford University
Stanford, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2Not yet recruitingINTERVENTIONAL

Effect of Vasopressin Versus Norepinephrine on Post-operative Mean Pulmonary Arterial Pressure Following Pulmonary Endarterectomy Surgery,

ClinicalTrials.gov · NCT07614438 · Registry updated: 2026-06-02

Condition / research focus: Anesthesia; Pulmonary Hypertension; Chronic Pulmonary Thromboembolism; Vasopressor
Sponsor: Fondation Hôpital Saint-Joseph
Countries with listed sites: France
Registry dates and results: Start: 2026-08-01. Completion: 2028-09-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vasopressin (drug)
Norepinephrine (drug)

Where the study takes place — 1 listed sites

Hôpital Marie Lannelongue
Le Plessis-Robinson, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Worldwide

Africa

Pan African Clinical Trial Registry ↗

Americas

Asia

Middle East

Europe

Oceania

Australia / New Zealand — ANZCTR ↗

Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.

Worldwide Study Finder

Loading registry information…

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find a study

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 17:56 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Not applicableNot yet recruitingINTERVENTIONAL

Terlipressin vs. Somatostatin in Cirrhotic Patients With Acute Variceal Bleeding and Renal Dysfunction

ClinicalTrials.gov · NCT07252401 · Registry updated: 2026-08-27

Condition / research focus: Liver Cirrhosis
Sponsor: General Hospital of Shenyang Military Region
Countries with listed sites: China
Registry dates and results: Start: 2026-09-25. Completion: 2028-03-31 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

2-4 mg of terlipressin (drug) — also listed as: Terlivaz
3 mg of somatostatin (drug) — also listed as: Stilamin

Where the study takes place — 1 listed sites

Department of Gastroenterology, General Hospital of Northern Theater Command (formerly called General Hospital of Shenyang Military Area)
Shenyang, Liaoning, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableEnrolling by invitationOBSERVATIONAL

International Multi-center Retrospective Study of Patients With Serum Sodium ≤110 mmol/L to Determine the Relationship Between Osmotic Demyelination Syndrome (ODS) and Rapid Correction of Hyponatremia

ClinicalTrials.gov · NCT07576036 · Registry updated: 2026-08-26

Condition / research focus: Hyponatremia Symptomatic; Osmotic Demyelination Syndrome; Cerebral Edema
Sponsor: Rochester General Hospital
Countries with listed sites: United States
Registry dates and results: Start: 2023-11-01. Completion: 2026-09-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Hypertonic 3% saline (drug) — also listed as: Desmopressin, 5% dextrose in water

Where the study takes place — 1 listed sites

University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

Bedtime Device Restriction and Desmopressin in PMNE.

ClinicalTrials.gov · NCT07776977 · Registry updated: 2026-08-24

Condition / research focus: Primary Monosymptomatic Nocturnal Enuresis
Sponsor: Al-Azhar University
Countries with listed sites: Egypt
Registry dates and results: Start: 2026-08-20. Completion: 2027-07 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desmopressin (drug)
Bedtime digital-device restriction (behavioral)

Where the study takes place — 1 listed sites

Department of Urology, Al-Hussein and Sayed Galal University Hospitals, Al-Azhar University
Cairo, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Copeptin and Acute Coronary Syndrome Without ST-segment Elevation

ClinicalTrials.gov · NCT01334645 · Registry updated: 2026-08-06

Condition / research focus: Chest Pain
Sponsor: University Hospital, Clermont-Ferrand
Countries with listed sites: France
Registry dates and results: Start: 2011-03. Completion: 2012-03 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Copeptin (other)

Where the study takes place — 1 listed sites

CHU Clermont-Ferrand
Clermont-Ferrand, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableNot yet recruitingINTERVENTIONAL

Terlipressin vs Placebo to Reduce Bleeding in Fibroid Surgery

ClinicalTrials.gov · NCT07746349 · Registry updated: 2026-08-05

Condition / research focus: Uterine Fibroids (Leiomyoma); Uterine Myoma; Leiomyoma
Sponsor: Sevil Cankaya
Countries with listed sites: No country reported
Registry dates and results: Start: 2026-08-01. Completion: 2027-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

terlipressin (vasoconstrictor) (drug)
Placebo (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Vasopressin for Septic Shock Pragmatic Trial

ClinicalTrials.gov · NCT06217562 · Registry updated: 2026-08-03

Condition / research focus: Septic Shock
Sponsor: Intermountain Health Care, Inc.
Countries with listed sites: United States
Registry dates and results: Start: 2024-02-01. Completion: 2026-06-06 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vasopressin (drug)
Recommendation to use a lower initiation threshold for vasopressin (other)
Recommendation to use a higher initiation threshold for vasopressin (other)

Where the study takes place — 13 listed sites

Cassia Regional Hospital
Burley, Idaho, United States
Site recruitment: Not reported
American Fork Hospital
American Fork, Utah, United States
Site recruitment: Not reported
Cedar City Hospital
Cedar City, Utah, United States
Site recruitment: Not reported
Layton Hospital
Layton, Utah, United States
Site recruitment: Not reported
Logan Regional Hospital
Logan, Utah, United States
Site recruitment: Not reported
Intermountain Medical Center
Murray, Utah, United States
Site recruitment: Not reported
McKay-Dee Hospital
Ogden, Utah, United States
Site recruitment: Not reported
Park City Hospital
Park City, Utah, United States
Site recruitment: Not reported
Utah Valley Hospital
Provo, Utah, United States
Site recruitment: Not reported
Riverton Hospital
Riverton, Utah, United States
Site recruitment: Not reported
LDS Hospital
Salt Lake City, Utah, United States
Site recruitment: Not reported
Alta View Hospital
Sandy City, Utah, United States
Site recruitment: Not reported
St. George Regional Hospital
St. George, Utah, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Intraoperative Continuous Terlipressin Infusion is Associated With Reduced Severe Postoperative Complications After Laparoscopic Hepatectomy: a Prospective Propensity Score-matched Cohort Study

ClinicalTrials.gov · NCT07719933 · Registry updated: 2026-07-28

Condition / research focus: Liver Neoplasms; Postoperative Complications
Sponsor: First Affiliated Hospital, Sun Yat-Sen University
Countries with listed sites: China
Registry dates and results: Start: 2024-04-01. Completion: 2025-05-14 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

terlipressin (drug)

Where the study takes place — 1 listed sites

The First Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1RecruitingINTERVENTIONAL

Mifepristone vs Misoprostol

ClinicalTrials.gov · NCT06502158 · Registry updated: 2026-07-24

Condition / research focus: Cervical Preparation
Sponsor: Montefiore Medical Center
Countries with listed sites: United States
Registry dates and results: Start: 2024-10-31. Completion: 2027-06 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Mifepristone (drug)
Misoprostol (drug) — also listed as: Cytotec

Where the study takes place — 1 listed sites

Montefiore Medical Center
The Bronx, New York, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4Enrolling by invitationINTERVENTIONAL

Randomized Controlled Clinical Study on the Prophylactic Intraoperative Use of Desmopressin in Complex Sellar Region Tumors

ClinicalTrials.gov · NCT07712328 · Registry updated: 2026-07-17

Condition / research focus: Craniopharyngiomas; Pituitary Macroadenoma; Sellar and Suprasellar Masses
Sponsor: Zhaoyun Zhang
Countries with listed sites: China
Registry dates and results: Start: 2026-06-02. Completion: 2028-09-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desmopressin (DDAVP) (drug)
Control (other)

Where the study takes place — 1 listed sites

Huashan Hospital
Shanghai, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

"SALT Trial" Study of Ascending Levels of Tolvaptan in Hyponatremia

ClinicalTrials.gov · NCT00072683 · Registry updated: 2026-07-13

Condition / research focus: Hyponatremias; Water Intoxication; Inappropriate ADH Syndrome; Water-Electrolyte Imbalances
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Countries with listed sites: United States
Registry dates and results: Start: 2003-04-01. Completion: 2005-12-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

tolvaptan (drug)
placebo matching tolvaptan (drug)

Where the study takes place — 23 listed sites

VA Greater Los Angeles Health Care Ctr
Los Angeles, California, United States
Site recruitment: Not reported
UCLA
Los Angeles, California, United States
Site recruitment: Not reported
UCSF Medical Center
San Francisco, California, United States
Site recruitment: Not reported
Aurora Denver Cardiology Association
Denver, Colorado, United States
Site recruitment: Not reported
University of Colorado Health Science Center
Denver, Colorado, United States
Site recruitment: Not reported
University of Florida Gainesville
Gainesville, Florida, United States
Site recruitment: Not reported
Charlotte Heart Group Research Ctr
Port Charlotte, Florida, United States
Site recruitment: Not reported
Medical College of Georgia
Augusta, Georgia, United States
Site recruitment: Not reported
Northwestern University
Chicago, Illinois, United States
Site recruitment: Not reported
University of Chicago
Chicago, Illinois, United States
Site recruitment: Not reported
University of Iowa Hospital
Iowa City, Iowa, United States
Site recruitment: Not reported
Minneapolis VA Medical Center
Minneapolis, Minnesota, United States
Site recruitment: Not reported
Washington University Ctr for Clinical Studies
St Louis, Missouri, United States
Site recruitment: Not reported
Mercury Street Medical
Butte, Montana, United States
Site recruitment: Not reported
Northshore University Hospital
Great Neck, New York, United States
Site recruitment: Not reported
Facility not reported
New York, New York, United States
Site recruitment: Not reported
University of North Carolina, Div. of Cardiology
Chapel Hill, North Carolina, United States
Site recruitment: Not reported
University Hospitals of Cleveland
Cleveland, Ohio, United States
Site recruitment: Not reported
Ohio State University Medical Center
Columbus, Ohio, United States
Site recruitment: Not reported
The Arthur P. Noyes Research Foundation
Norristown, Pennsylvania, United States
Site recruitment: Not reported
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
Site recruitment: Not reported
Baptist Clinical Research Ctr
Memphis, Tennessee, United States
Site recruitment: Not reported
Tennessee Center for Clinical Trials
Tullahoma, Tennessee, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableActive, not recruitingINTERVENTIONAL

Effect of Terlipressin for Intraoperative Blood Pressure Management in Kidney Transplantation

ClinicalTrials.gov · NCT06855758 · Registry updated: 2026-07-13

Condition / research focus: Kidney Transplant; Delayed Graft Function; Intraoperative Hypotension
Sponsor: Beijing Friendship Hospital
Countries with listed sites: China
Registry dates and results: Start: 2025-03-06. Completion: 2027-06 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

terlipressin (drug)
Placebo (Normal Saline) (drug)

Where the study takes place — 1 listed sites

Beijing Friendship Hospital
Beijing, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableNot yet recruitingOBSERVATIONAL

Effect of Adding Vasopressin on Cardiac Output, Blood Pressure, Diuresis, and Tissue Perfusion Indices in Patients With Septic Shock

ClinicalTrials.gov · NCT07697144 · Registry updated: 2026-07-13

Condition / research focus: Septic Shock and Use of Vasopressin
Sponsor: Assistance Publique - Hôpitaux de Paris
Countries with listed sites: France
Registry dates and results: Start: 2026-08-01. Completion: 2029-09-01 (may be estimated). No results posted in this registry response.

Products and interventions (0)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Where the study takes place — 8 listed sites

CHU d'Angers
Angers, France
Site recruitment: Not reported
CH de Dieppe
Dieppe, France
Site recruitment: Not reported
Hôpital Bicêtre
Le Kremlin-Bicêtre, France
Site recruitment: Not reported
GHE, Hôpital Louis Pradel, HCL
Lyon, France
Site recruitment: Not reported
GHS - Hôpital Lyon Sud, HCL
Lyon, France
Site recruitment: Not reported
Hôpital Nord, AP-HM
Marseille, France
Site recruitment: Not reported
CHU Rennes - Site Pontchaillou
Rennes, France
Site recruitment: Not reported
Hôpital Hautepierre, Hôpitaux Universitaires de Strasbourg
Strasbourg, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Study of Ascending Levels of Tolvaptan in Hyponatremia

ClinicalTrials.gov · NCT00201994 · Registry updated: 2026-07-13

Condition / research focus: Hyponatremia
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Countries with listed sites: Germany
Registry dates and results: Start: 2003-11-01. Completion: 2005-07-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tolvaptan (drug) — also listed as: Samsca, OPC-41061
Placebo (drug)

Where the study takes place — 1 listed sites

Universitatskilinikum Carl
Gustav Carus, Dresden, Germany
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Serum Biomarkers to Predict Response to Angiotensin II in Septic Shock

ClinicalTrials.gov · NCT05824767 · Registry updated: 2026-07-02

Condition / research focus: Septic Shock; Vasodilatory Shock
Sponsor: University of New Mexico
Countries with listed sites: United States
Registry dates and results: Start: 2023-04-17. Completion: 2025-03-12 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Angiotensin II (drug) — also listed as: Giapreza

Where the study takes place — 1 listed sites

University of New Mexico Health Sciences Center
Albuquerque, New Mexico, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4Not yet recruitingINTERVENTIONAL

Angiotensin II for Post Cardiac Surgery Vasoplegia (ANGII_V)

ClinicalTrials.gov · NCT07671365 · Registry updated: 2026-06-26

Condition / research focus: Vasoplegic Shock; Cardiopulmonary Bypass; Vasoplegia
Sponsor: Methodist Healthcare System of San Antonio
Countries with listed sites: No country reported
Registry dates and results: Start: 2026-07. Completion: 2030-08 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Angiotensin II (Giapreza®) (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase not reported / not applicableActive, not recruitingOBSERVATIONAL

Samsca Post-marketing General Drug Use-results Survey in Patients With Hyponatremia in SIADH

ClinicalTrials.gov · NCT04790175 · Registry updated: 2026-06-22

Condition / research focus: Antidiuretic Hormone, Inappropriate Secretion
Sponsor: Otsuka Pharmaceutical Co., Ltd.
Countries with listed sites: Japan
Registry dates and results: Start: 2021-03-29. Completion: 2030-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tolvaptan (SAMSCA) (drug)

Where the study takes place — 1 listed sites

Pharmacovigilance Department
Osaka, Osaka, Japan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4Active, not recruitingINTERVENTIONAL

Angiotensin 2 for AKI After OLT

ClinicalTrials.gov · NCT04592744 · Registry updated: 2026-06-12

Condition / research focus: Cirrhosis, Liver; End Stage Liver DIsease; Acute Kidney Injury; Liver Transplant; Complications
Sponsor: University of California, Los Angeles
Countries with listed sites: United States
Registry dates and results: Start: 2022-04-08. Completion: 2026-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Angiotensin II (drug)
Norepinephrine (drug) — also listed as: Vasopressin, Epinephrine

Where the study takes place — 1 listed sites

Ronald Reagan UCLA Medical Center, Department of Anesthesiology & Perioperative Medicine
Los Angeles, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Vasopressin and Epinephrine Versus Epinephrine Alone in Cardiac Arrest

ClinicalTrials.gov · NCT00127907 · Registry updated: 2026-06-11

Condition / research focus: Cardiac Arrest
Sponsor: Hospices Civils de Lyon
Countries with listed sites: France
Registry dates and results: Start: 2004-05-02. Completion: 2007-10-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

epinephrine (1 mg/1 mL) (drug)
arginine-vasopressin (40 UI/2 mL) (drug)

Where the study takes place — 1 listed sites

Centre Hospitalier Lyon Sud
Pierre-Bénite, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2 / Phase 3CompletedINTERVENTIONAL

Intranasal Vasopressin Treatment in Children With Autism

ClinicalTrials.gov · NCT03204786 · Registry updated: 2026-06-04

Condition / research focus: Autism; Autism Spectrum Disorder; ASD
Sponsor: Stanford University
Countries with listed sites: United States
Registry dates and results: Start: 2018-02-20. Completion: 2024-03-18 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vasopressin (USP) Injectable Solution [Vasostrict] (drug)
Placebo (drug)

Where the study takes place — 1 listed sites

Stanford University
Stanford, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2Not yet recruitingINTERVENTIONAL

Effect of Vasopressin Versus Norepinephrine on Post-operative Mean Pulmonary Arterial Pressure Following Pulmonary Endarterectomy Surgery,

ClinicalTrials.gov · NCT07614438 · Registry updated: 2026-06-02

Condition / research focus: Anesthesia; Pulmonary Hypertension; Chronic Pulmonary Thromboembolism; Vasopressor
Sponsor: Fondation Hôpital Saint-Joseph
Countries with listed sites: France
Registry dates and results: Start: 2026-08-01. Completion: 2028-09-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vasopressin (drug)
Norepinephrine (drug)

Where the study takes place — 1 listed sites

Hôpital Marie Lannelongue
Le Plessis-Robinson, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →